title: Case presentation: nephrolithiasis in a patient treated with atazanavir.
abstract: Of the recently approved antiretroviral protease inhibitors, atazanavir has become a popular medication for the treatment of HIV infection. The advantages of an atazanavir-based regimen include a favorable side effect profile, low impact on lipids, low pill burden, and daily dosing. These have made it a favorable choice for antiretroviral treatment. As more experience is gained with newer antiretroviral medications, additional side effects become apparent. Recent reports have highlighted occurrences of nephrolithiasis in patients using atazanavir-based regimens. The authors present a case of a patient who experienced nephrolithiasis while taking combination antiretroviral therapy that included atazanavir.
authors.affiliation: HIV Program at Christiana Care Health System in Delaware, USA.
authors.forename: Carolyn
authors.initials: C
authors.lastname: Savini
authors.forename: Christopher
authors.initials: C
authors.lastname: James
authors.forename: Susan
authors.initials: S
authors.lastname: Wilson
authors.forename: Heather
authors.initials: H
authors.lastname: Martin
authors.forename: Susan
authors.initials: S
authors.lastname: Szabo
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Scotto
mesh_terms: D000328:Adult; D000069446:Atazanavir Sulfate; D005260:Female; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D006801:Humans; D053040:Nephrolithiasis / Q000139:chemically induced* / Q000150:complications; D009842:Oligopeptides / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*
chemical_list: D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate